Literature DB >> 17227592

Endometriosis: disease pathophysiology and the role of prostaglandins.

Meng-Hsing Wu1, Yutaka Shoji, Pei-Chin Chuang, Shaw-Jenq Tsai.   

Abstract

Endometriosis is considered to be a polygenic disease with a complex, multifactorial aetiology that affects about 10% of women in the reproductive age. Women with endometriosis have symptoms that include chronic pelvic pain, dysmenorrhoea and dyspareunia, significantly reducing their quality of life. Endometriosis is also the primary cause of infertility in women, with the prevalence rate ranging from 20% to 50%. The high prevalence and severe outcomes of this disease have made it a major public health concern in modern society. Currently, the mechanism(s) responsible for the initiation and promotion of this disease remains obscure. In this review, we focus on the expression, regulation and action of prostaglandins in the cellular and molecular mechanisms that contribute to the development and/or maintenance of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227592     DOI: 10.1017/S146239940700021X

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  22 in total

Review 1.  Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why.

Authors:  Bruce A Lessey; J Julie Kim
Journal:  Fertil Steril       Date:  2017-06-14       Impact factor: 7.329

2.  Dose-Dependent Decreased Fertility in Response to the Burden of Endometriosis in a Murine Model.

Authors:  Ana C J S Rosa-E-Silva; Julio C Rosa-E-Silva; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  Reprod Sci       Date:  2019-07-05       Impact factor: 3.060

3.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Authors:  JeHoon Lee; Sakhila K Banu; Robert C Burghardt; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Biol Reprod       Date:  2013-03-28       Impact factor: 4.285

4.  Cyclic adenosine 3',5'-monophosphate response element-binding protein and CCAAT/enhancer-binding protein mediate prostaglandin E2-induced steroidogenic acute regulatory protein expression in endometriotic stromal cells.

Authors:  Chih-Chao Hsu; Chun-Wun Lu; Bu-Miin Huang; Meng-Hsing Wu; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

5.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

Authors:  Sakhila K Banu; JeHoon Lee; V O Speights; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Mol Endocrinol       Date:  2009-04-30

6.  Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis.

Authors:  Pei-Chin Chuang; Yiu-Juian Lin; Meng-Hsing Wu; Lih-Yuh C Wing; Yutaka Shoji; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

7.  AUF1 p42 isoform selectively controls both steady-state and PGE2-induced FGF9 mRNA decay.

Authors:  Tsung-Ming Chen; Chien-Hui Hsu; Shaw-Jenq Tsai; H Sunny Sun
Journal:  Nucleic Acids Res       Date:  2010-08-16       Impact factor: 16.971

8.  Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.

Authors:  Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2012-03-13       Impact factor: 5.810

9.  Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis.

Authors:  Halima Rakhila; Nathalie Bourcier; Ali Akoum; Marc Pouliot
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

10.  Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells.

Authors:  Korosh Khanaki; Ali Motavalizadeh Ardekani; Alieh Ghassemzadeh; Vahideh Shahnazi; Mohammad Reza Sadeghi; Masoud Darabi; Amir Mehdizadeh; Abotaleb Saremi; Jafar Soleimani-Rad; Ali Reza Imani; Mohammad Nouri; Ali Rahimipour
Journal:  Iran J Reprod Med       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.